Oxford Biomedica (LSE:OXB) is a quality and innovation-led CDMO operating in Oxford, UK, Boston, US, Durham, US, Lyon and Strasbourg, France. We have 25 years experience and proven clinical and commercial capabilities for manufacturing viral vectors.